Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Introduction. Artificial intelligence (AI) is a technology that simulates human brain data processing, its intellectual behavior and critical thinking. Sophisticated AI models can potentially improve patient management by speeding up processes and increasing their accuracy and efficiency at a lower cost of human resources. Compared to other specialties, use of AI in gynecology remains in its infancy. It is important to understand that the available methods for clinical imaging have certain limitations, namely clinician’s workload and data variably interpreted by different doctors. AI, in turn, has the potential to overcome these limitations while increasing diagnostic accuracy.Aim: to structure and analyze current published data on AI use in gynecology.Materials and Methods. A search for primary sources was carried out in the electronic databases PubMed, eLibrary and Google Scholar. The search queries included the following keywords "artificial intelligence", "gynecology", "endometrial cancer", "endometriosis", "ovarian cancer", "diagnostics", "oncogynecology" retrieved from February 2014 to February 2024. Articles were assessed according to PRISMA guidelines. After identification, before the screening stage, duplicates were excluded. At the screening stage, the titles and annotations of the identified articles were analyzed for eligibility to the review topic as well as for available full-text versions; abstracts and letters to the editorial board in scientific journals were excluded at this stage. 685 full-text articles were evaluated for eligibility, the inclusion criteria were as follows: publication in Russian or English; the study describes use of AI technologies in diagnostics or treatment of gynecological diseases. All disagreements between authors were resolved by consensus. Ultimately, 80 primary sources were included in this review.Results. AI-based systems have succeeded in image analyzing and interpreting and over the past decade have become powerful tools that have revolutionized the field of gynecological imaging. In the studies analyzed, AI was able to provide faster and more accurate forecasts and diagnostics, increasing the overall effectiveness of gynecological care. It is important to note that AI cannot fully replace doctors, but it can perfectly integrate into clinical practice, helping in the decision-making process and reducing errors in differential diagnosis and variability of interaction between different specialists. In the field of oncogynecology, undoubtedly one of the most promising aspects is the possibility of better and especially early diagnostics and, ultimately, improved patient survival.Conclusion. A great success has been achieved so far, and AI use is expected to extend in the next few years. In fact, it will take a very long way to go before AI-based technologies are fully integrated into clinical practice.
Introduction. Artificial intelligence (AI) is a technology that simulates human brain data processing, its intellectual behavior and critical thinking. Sophisticated AI models can potentially improve patient management by speeding up processes and increasing their accuracy and efficiency at a lower cost of human resources. Compared to other specialties, use of AI in gynecology remains in its infancy. It is important to understand that the available methods for clinical imaging have certain limitations, namely clinician’s workload and data variably interpreted by different doctors. AI, in turn, has the potential to overcome these limitations while increasing diagnostic accuracy.Aim: to structure and analyze current published data on AI use in gynecology.Materials and Methods. A search for primary sources was carried out in the electronic databases PubMed, eLibrary and Google Scholar. The search queries included the following keywords "artificial intelligence", "gynecology", "endometrial cancer", "endometriosis", "ovarian cancer", "diagnostics", "oncogynecology" retrieved from February 2014 to February 2024. Articles were assessed according to PRISMA guidelines. After identification, before the screening stage, duplicates were excluded. At the screening stage, the titles and annotations of the identified articles were analyzed for eligibility to the review topic as well as for available full-text versions; abstracts and letters to the editorial board in scientific journals were excluded at this stage. 685 full-text articles were evaluated for eligibility, the inclusion criteria were as follows: publication in Russian or English; the study describes use of AI technologies in diagnostics or treatment of gynecological diseases. All disagreements between authors were resolved by consensus. Ultimately, 80 primary sources were included in this review.Results. AI-based systems have succeeded in image analyzing and interpreting and over the past decade have become powerful tools that have revolutionized the field of gynecological imaging. In the studies analyzed, AI was able to provide faster and more accurate forecasts and diagnostics, increasing the overall effectiveness of gynecological care. It is important to note that AI cannot fully replace doctors, but it can perfectly integrate into clinical practice, helping in the decision-making process and reducing errors in differential diagnosis and variability of interaction between different specialists. In the field of oncogynecology, undoubtedly one of the most promising aspects is the possibility of better and especially early diagnostics and, ultimately, improved patient survival.Conclusion. A great success has been achieved so far, and AI use is expected to extend in the next few years. In fact, it will take a very long way to go before AI-based technologies are fully integrated into clinical practice.
O câncer de colo de útero, causado principalmente pelo HPV, é prevalente em mulheres, especialmente em países em desenvolvimento devido ao acesso limitado a rastreamento e vacinação. A mortalidade é alta onde esses serviços são escassos. A prevenção envolve vacinação e rastreamento regular. Esta revisão visa estimar a sobrevida em cinco anos. A metodologia incluiu estudos observacionais sobre a sobrevida em 5 anos de mulheres com câncer de colo de útero. Bases de dados como Google Scholar, ScienceDirect e MEDLINE foram usadas. Dois revisores independentes realizaram triagem e extração de dados. A escala de Newcastle-Ottawa avaliou o risco de viés. Análises estatísticas foram feitas usando JASP, versão 0.18.3, com meta-análise e testes de sensibilidade. Após a busca sistemática, 11.738 artigos foram identificados, resultando em 13 estudos incluídos na revisão após triagem e avaliação. A sobrevida em 5 anos foi de 0,76 (IC 95% [0,67, 0,85]), com alta heterogeneidade (I² = 99,452%). A maioria dos estudos apresentou risco de viés aceitável. Análises de sensibilidade confirmaram a robustez dos resultados. Esta meta-análise estima a sobrevida em 5 anos de mulheres com câncer de colo de útero em 0,76 (IC 95% [0,67, 0,85]), alinhada com a literatura existente. A alta heterogeneidade (I² de 99,452%) reflete diferenças nos estudos incluídos. Limitações incluem possíveis viéses de seleção e publicação. Os achados reforçam a necessidade de melhorar rastreamento e tratamento, especialmente em regiões com acesso limitado a cuidados de saúde. Futuras pesquisas devem explorar fatores de variabilidade na sobrevida e realizar análises de subgrupos para obter estimativas mais precisas.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.